Samsung Biologics and key partners are taking a commemorative photo after signing an 'ESG Management Partnership.' <br>[Photo by Samsung Biologics]

Samsung Biologics and key partners are taking a commemorative photo after signing an 'ESG Management Partnership.'
[Photo by Samsung Biologics]

View original image

[Asia Economy Reporter Lee Gwan-ju] On the 13th, Samsung Biologics held an 'ESG Partnership Signing Ceremony' with key partners at its headquarters in Songdo, Incheon, to strengthen the ESG (Environmental, Social, and Governance) management capabilities of its partners.


The signing ceremony was attended by representatives and executives from seven partner companies, including Samsung Biologics, Global Life Sciences Solutions Korea, Merck Life Science, Saint-Gobain Korea, Sartorius Korea Biotech, Thermo Fisher Scientific, Avanto Performance Materials Korea, and Korea Pol Co., Ltd.


Samsung Biologics aims to achieve carbon neutrality (net zero) by 2050. Accordingly, the company signed the agreement based on specific carbon neutrality achievement plans discussed with partners who account for more than 80% of the company's total greenhouse gas emissions.


Through the agreement, Samsung Biologics and the seven partners will establish carbon neutrality goals and plans in accordance with the Paris Agreement and implement activities to reduce carbon emissions. In particular, Samsung Biologics encourages building roadmaps through participation in initiatives such as the Science Based Targets initiative (SBTi) and RE100.


They also agreed to disclose each company's greenhouse gas emissions and strengthen monitoring of greenhouse gas emissions across the entire supply chain. The partners agreed to practice ESG management by promoting human rights management, safety management, and contributing to the development of local communities.



John Rim, President of Samsung Biologics, said, "We hope this partnership will serve as an opportunity for Samsung Biologics and its partners to reaffirm their commitment to spreading ESG management," adding, "Samsung Biologics will continue to actively support the ESG management of its partners and create a sustainable future together."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing